Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Won Yu Kang"'
Autor:
Hae Eun, Yun, You-Jeong, Ki, Weon, Kim, Su Hyun, Kim, Kyung Hwan, Kim, Ming Gu, Lee, Yeong Min, Lim, Jae Min, Kim, Won Yu, Kang, In Young, Kwon, So Young, Cha, Jang Hyun, Cho
Publikováno v:
Coronary Artery Disease. 33:643-647
Drug-eluting stents (DES) significantly improved angiographic and clinical outcomes compared with bare-metal stents in patients with diabetes. The clinical effects of BioMime sirolimus-eluting stent (SES) in patients with diabetes have not been evalu
Autor:
Jang Hyun Cho, Min Gu Lee, Myung Ho Jeong, Soo Sung Kim, Mi Yang Kim, Kyung Sim Lee, Su Hyun Kim, Won Yu Kang, Ji Hye Lee, Young Keun Ahn, Yoon Ho Lee, Hyun Soo Kim
Publikováno v:
Cardiovascular Drugs and Therapy
Background/Aims The progression and development of congestive heart failure is still considered a large problem despite the existence of revascularization therapies and optimal, state-of-the-art medical services. An acute myocardial infarction (AMI)
Autor:
Romain Didier, Smita I. Negi, Ron Waksman, Umberto Campia, Ricardo O. Escarcega, Edward Koifman, Rebecca Torguson, Won Yu Kang, Nevin C. Baker, Michael J. Lipinski, Nelson L. Bernardo, Sarkis Kiramijyan
Publikováno v:
Cardiovascular Revascularization Medicine. 17:134-137
Purpose To report a case of a thrombosed GORE® VIABAHN® endoprosthesis stent-graft in the femoral artery (SFA) and popliteal artery managed using the pulse-spray technique and complicated by compartment syndrome of the lower leg of the affected lim
Publikováno v:
Journal of Cardiology. 65:121-127
BackgroundThe CHA2DS2VASc score has been used to evaluate the risk of thromboembolic events in atrial fibrillation. However, because all the components of CHA2DS2VASc are important cardiovascular risk factors, we decided to evaluate the effectiveness
Autor:
Hong Ju An1, Won Yu Kang1 gpkwy@naver.com, Chung Kang1, Dong In Nam1, Il Hyung Jung1, Hoon Kang1, Sang Sun Lee1, Ho Yeong Song1, Sang Cheol Cho1, Sun Ho Hwang1, Wan Kim1
Publikováno v:
Journal of the Korean Geriatrics Society / Noinbyeong. Jun2014, Vol. 18 Issue 2, p89-92. 4p.
Autor:
Il Hyung Jung, Hong Ju An, Sang Sun Lee, Hoon Kang, Wan Kim, Sang Cheol Cho, Sun Ho Hwang, Chung Kang, Won Yu Kang, Ho Yeong Song, Dong In Nam
Publikováno v:
Journal of the Korean Geriatrics Society. 18:89-92
Endovascular procedures have been proposed as minimally invasive alternative treatments, allowing safe and effective aortic aneurysm repair. Despite the potential benefits, endovascular stent grafting may elicit an unexpected systemic inflammatory re
Publikováno v:
Hip & Pelvis. Dec2012, Vol. 24 Issue 4, p333-337. 5p.
Autor:
Seung-Woon Rha, Woo Yong Jung, Ki Chang Kim, Cheol Ung Choi, Eung Ju Kim, Dong Joo Oh, Ji Hoon Ahn, Do Hoi Kim, Sang-Ho Park, Woong Gil Choi, Yoon Hyung Cho, Young Guk Ko, Sang Min Park, Min Woong Kim, Jang Ho Bae, Ji Yong Jang, Soohyun Kim, Jang Hyun Cho, Won Yu Kang, Seung Jin Lee, Jung Min Bong, Joo Han Kim, Sang-Min Kim, Jae Bin Seo, Ae Yong Hur
Publikováno v:
Trials
TRIALS(17)
TRIALS(17)
Background The self-expandable COMPLETE™ stent (Medtronic) has greater elasticity, allowing it to regain its shape after the compression force reduces, and has higher trackability, thus is easier to maneuver through tortuous vessels, whereas the ba
Autor:
Sun Ho Hwang, Weon Kim, Sang Woo Jeong, Gyu Ik Lee, Young Eun Jo, Won Yu Kang, Hyun Gee Moon, Boram Youn, Wan Kim, Sang Cheol Cho
Publikováno v:
International journal of cardiology. 228
Background Acute arterial occlusion in lower extremity is an urgent condition which occurs when there is an abrupt interruption of blood flow into an extremity. Reperfusion through early intervention can increase limb salvage and decrease mortality.
Autor:
Romain Didier, Hideaki Ota, Ron Waksman, Rebecca Torguson, Umberto Campia, Edward Koifman, Won Yu Kang, Ricardo O. Escarcega, Marco A. Magalhaes, Michael J. Lipinski, Nelson L. Bernardo, Sarkis Kiramijyan, Smita I. Negi, Nevin C. Baker
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 17(3)
Currently, percutaneous endovascular intervention is considered a first line of therapy for treating patients with critical limb ischemia. As the result of remarkable development of techniques and technologies, percutaneous endovascular intervention